|
氮卓斯汀N-氧化物市场分析报告
|
FDC Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... /intestinals/ORS, anti-haemorrhagics, anti-oxidants, anti-spasmodics, antibiotics/antibacterials, antiulcerants ... development bulk drug products consist of Azelastine HCL, Brinzolamide, Duloxetine HCl, Gemifloxacine ...
|
|
|